Mortality associated with the treatment of HCV with direct-acting antivirals

Anne Laurain¹, Laura Kramer¹, Philippe Sultanik¹, Anaïs Vallet-Pichard¹, Philippe Sogni¹, Stanislas Pol¹

Affiliations

PMID: 28341750
DOI: 10.1136/gutjnl-2017-313869

Comment

Mortality associated with the treatment of HCV with direct-acting antivirals

Anne Laurain et al. Gut. 2018 Jan.

. 2018 Jan;67(1):197-198.

doi: 10.1136/gutjnl-2017-313869. Epub 2017 Mar 23.

Authors

Anne Laurain¹, Laura Kramer¹, Philippe Sultanik¹, Anaïs Vallet-Pichard¹, Philippe Sogni¹, Stanislas Pol¹

Affiliation

¹ Université Paris Descartes; APHP, Unité d'Hépatologie, Hôpital Cochin; INSERM U1223 and USM20, Institut Pasteur, Paris, France.

PMID: 28341750
DOI: 10.1136/gutjnl-2017-313869

No abstract available

Keywords: HEPATITIS C.

PubMed Disclaimer

Conflict of interest statement

Competing interests: LK is a board member of Gilead. AV-P received personal fees from Gilead, BMS, Janssen, MSD, Abbvie, Roche. PS was board member of Gilead and BMS. Workshop or meeting invitation: Gilead, BMS, MSD, AbbVie, Mayoloy-Spindler, Janssen. SP was speaker for BMS, Boehringer Ingelheim, Janssen Gilead, Roche, MSD, Novartis, Abbvie; received grants from BMS, Gilead, Roche, MSD and is board member of BMS, Boehringer Ingelheim, Janssen, Gilead, Roche, MSD, Abbvie.

Comment on

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.
Welzel TM, Petersen J, Herzer K, Ferenci P, Gschwantler M, Wedemeyer H, Berg T, Spengler U, Weiland O, van der Valk M, Rockstroh J, Peck-Radosavljevic M, Zhao Y, Jimenez-Exposito MJ, Zeuzem S. Welzel TM, et al. Gut. 2016 Nov;65(11):1861-1870. doi: 10.1136/gutjnl-2016-312444. Epub 2016 Sep 7. Gut. 2016. PMID: 27605539 Free PMC article.

Cited by

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
Laurain A, Metivier S, Haour G, Larrey D, Dorival C, Hezode C, Zoulim F, Marcellin P, Bourliere M, Zarski JP, Thabut D, Alric L, Ganne-Carrie N, Cales P, Bronowicki JP, Riachi G, Geist C, Causse X, Abergel A, Chazouilleres O, Mathurin P, Guyader D, Samuel D, Tran A, Loustaud-Ratti V, Petrov-Sanchez V, Diallo A, Luzivika-Nzinga C, Fontaine H, Carrat F, Pol S; ANRS/AFEF HEPATHER study group. Laurain A, et al. BMC Infect Dis. 2019 Apr 2;19(1):300. doi: 10.1186/s12879-019-3923-5. BMC Infect Dis. 2019. PMID: 30940090 Free PMC article.
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study.
Lam L, Pol S, Cohen A, Carrat F. Lam L, et al. Drugs. 2023 Sep;83(13):1207-1213. doi: 10.1007/s40265-023-01918-0. Epub 2023 Jul 12. Drugs. 2023. PMID: 37436681

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Mortality associated with the treatment of HCV with direct-acting antivirals

Affiliation

Mortality associated with the treatment of HCV with direct-acting antivirals

Authors

Affiliation

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources